{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-035256","form_type":"8-K","ticker":"IPSC","cik":"0001850119","company_name":"Century Therapeutics, Inc.","filed_at":"2026-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.532354+00:00","generated_at":"2026-05-15T08:53:19.219851+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Century Therapeutics updates ATM program; $131.6M remaining under $150M facility","bullets":["New prospectus supplement filed March 26, 2026 for existing ATM program under effective shelf.","Up to $150M in common stock may be sold via ATM; $18.38M already sold.","$131.62M remains available for future issuance through TD Securities as agent.","Goodwin Procter LLP opinion on share validity included as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-035256","json":"https://secwatch.observer/filing/0001104659-26-035256.json","markdown":"https://secwatch.observer/filing/0001104659-26-035256.md","text":"https://secwatch.observer/filing/0001104659-26-035256.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850119/000110465926035256/0001104659-26-035256-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850119/000110465926035256/tm269823d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:53:19.219851+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}